Related Experiment Video
Updated: Feb 1, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade
Zhezhu Han1,2, Dongxu Kang1,2, Yeonsoo Joo1,3
1Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.
Abstract:
Transforming growth factor (TGF)-β signaling is increasingly recognized as a key driver in cancer. In progressive cancer tissues, TGF-β promotes tumor formation, and its increased expression often correlates with cancer malignancy. In this study, we utilized adenoviruses expressing short hairpin RNAs against TGF-β1 and TGF-β2 to investigate the role of TGF-β downregulation in cancer cell death. We found that the downregulation of TGF-β increased the phosphorylation of several SAPKs, such as p38 and JNK. Moreover, reactive oxygen species (ROS) production was also increased by TGF-β downregulation, which triggered Akt inactivation and NOX4 increase-derived ROS in a cancer cell-type-specific manner. We also revealed the possibility of substantial gene fluctuation in response to TGF-β downregulation related to SAPKs. The expression levels of Trx and GSTM1, which encode inhibitory proteins that bind to ASK1, were reduced, likely a result of the altered translocation of Smad complex proteins rather than from ROS production. Instead, both ROS and ROS-mediated ER stress were responsible for the decrease in interactions between ASK1 and Trx or GSTM1. Through these pathways, ASK1 was activated and induced cytotoxic tumor cell death via p38/JNK activation and (or) induction of ER stress.
Insights
Downregulating transforming growth factor-beta (TGF-β) in cancer cells activates stress pathways, leading to cancer cell death. This involves reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress, ultimately activating ASK1.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Transforming growth factor-beta (TGF-β) signaling is a critical factor in cancer progression and malignancy.
- Increased TGF-β expression correlates with advanced cancer stages.
Purpose of the Study:
- To investigate the impact of TGF-β downregulation on cancer cell death.
- To elucidate the molecular mechanisms underlying TGF-β's role in cancer cell survival and apoptosis.
Main Methods:
- Utilized adenoviruses expressing short hairpin RNAs to downregulate TGF-β1 and TGF-β2.
- Analyzed the phosphorylation of stress-activated protein kinases (SAPKs) like p38 and JNK.
- Measured reactive oxygen species (ROS) production and Akt activity.
- Assessed changes in NOX4, Trx, GSTM1, and ASK1 interactions.
- Investigated endoplasmic reticulum (ER) stress markers.
Main Results:
- TGF-β downregulation increased SAPK phosphorylation (p38, JNK) and ROS production.
- Akt was inactivated, and NOX4-derived ROS increased in a cell-type-specific manner.
- Expression of Trx and GSTM1, ASK1 inhibitors, decreased.
- ROS and ER stress disrupted ASK1-inhibitor interactions, leading to ASK1 activation.
- Activated ASK1 induced cancer cell death via p38/JNK activation and ER stress.
Conclusions:
- TGF-β downregulation triggers cytotoxic pathways in cancer cells.
- The mechanism involves ROS production, ER stress, and ASK1 activation.
- Targeting TGF-β signaling presents a potential therapeutic strategy for cancer treatment.
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Cascades
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
What is Cell Signaling?
Cell-surface Signaling

